Announcements, partnerships, and the story of Indian precision oncology in the making.
Bringing ultra-sensitive lung cancer testing to India through our partnership with Biofidelity, on the hardware Indian labs already own.
The precision-oncology gap is nowhere sharper than in India. We chose to launch here first — and this is what that changes for patients.
Comprehensive genomic profiling on our own NGS platform — engineered for Indian throughput, Indian pricing, and Indian oncology practice.